loading

Sab Biotherapeutics Inc (SABS) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
기간 3개월 3개월 3개월 3개월 3개월
Operating Expenses
16.90%
23.38
20.00 15.77 12.68 9.7321
Operating Income/Loss
16.90%
-23.38
-20.00 -15.77 -12.68 -9.7321
Nonoperating Income/Loss
21.51%
0.886
1.1289 -1.0905 58.12 -0.3822
Net Income/Loss
19.20%
-22.49
-18.87 -16.86 45.45 -10.11
Basic Average Shares
48.91%
79.75
53.56 9.5613 10.66 9.2945
Diluted Average Shares
48.91%
79.75
53.56 31.04 77.86 9.2945
Basic Earnings Per Share
20.00%
-0.28
-0.35 -0.51 0.50 -1.09
Diluted Earnings Per Share
20.00%
-0.28
-0.35 -0.46 -0.21 -1.09
$6.58
price down icon 4.22%
$9.94
price down icon 3.21%
$5.53
price down icon 3.66%
$11.27
price down icon 6.16%
$18.60
price down icon 1.74%
WVE WVE
$3.13
price down icon 1.88%
자본화:     |  볼륨(24시간):